Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.
Otter AD, Jones S, Hicks B, Bailey D, Callaby H, Houlihan C, Rampling T, Gordon NC, Selman H, Satheshkumar PS, Townsend M, Mehta R, Pond M, Jones R, Wright D, Oeser C, Tonge S, Linley E, Hemingway G, Coleman T, Millward S, Lloyd A, Damon I, Brooks T, Vipond R, Rowe C, Hallis B. Otter AD, et al. Among authors: hallis b. Nat Commun. 2023 Sep 23;14(1):5948. doi: 10.1038/s41467-023-41587-x. Nat Commun. 2023. PMID: 37741831 Free PMC article.
Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Zuo J, Dowell AC, Pearce H, Verma K, Long HM, Begum J, Aiano F, Amin-Chowdhury Z, Hoschler K, Brooks T, Taylor S, Hewson J, Hallis B, Stapley L, Borrow R, Linley E, Ahmad S, Parker B, Horsley A, Amirthalingam G, Brown K, Ramsay ME, Ladhani S, Moss P. Zuo J, et al. Among authors: hallis b. Nat Immunol. 2021 May;22(5):620-626. doi: 10.1038/s41590-021-00902-8. Epub 2021 Mar 5. Nat Immunol. 2021. PMID: 33674800 Free PMC article.
Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.
Zuo J, Dowell AC, Pearce H, Verma K, Long HM, Begum J, Aiano F, Amin-Chowdhury Z, Hoschler K, Brooks T, Taylor S, Hewson J, Hallis B, Stapley L, Borrow R, Linley E, Ahmad S, Parker B, Horsley A, Amirthalingam G, Brown K, Ramsay ME, Ladhani S, Moss P. Zuo J, et al. Among authors: hallis b. Nat Immunol. 2021 Jul;22(7):928. doi: 10.1038/s41590-021-00957-7. Nat Immunol. 2021. PMID: 34017126 Free PMC article. No abstract available.
mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralization of P.1 Brazilian variant.
Parry H, Tut G, Bruton R, Faustini S, Stephens C, Saunders P, Bentley C, Hilyard K, Brown K, Amirthalingam G, Charlton S, Leung S, Chiplin E, Coombes NS, Bewley KR, Penn EJ, Rowe C, Otter A, Watts R, D'Arcangelo S, Hallis B, Makin A, Richter A, Zuo J, Moss P. Parry H, et al. Among authors: hallis b. Elife. 2021 Sep 29;10:e69375. doi: 10.7554/eLife.69375. Elife. 2021. PMID: 34586068 Free PMC article.
Extended interval BNT162b2 vaccination enhances peak antibody generation.
Parry H, Bruton R, Stephens C, Bentley C, Brown K, Amirthalingam G, Hallis B, Otter A, Zuo J, Moss P. Parry H, et al. Among authors: hallis b. NPJ Vaccines. 2022 Jan 27;7(1):14. doi: 10.1038/s41541-022-00432-w. NPJ Vaccines. 2022. PMID: 35087066 Free PMC article.
Serological surveillance of SARS-CoV-2: Six-month trends and antibody response in a cohort of public health workers.
Harris RJ, Whitaker HJ, Andrews NJ, Aiano F, Amin-Chowdhury Z, Flood J, Borrow R, Linley E, Ahmad S, Stapley L, Hallis B, Amirthalingam G, Höschler K, Parker B, Horsley A, Brooks TJG, Brown KE, Ramsay ME, Ladhani SN. Harris RJ, et al. Among authors: hallis b. J Infect. 2021 May;82(5):162-169. doi: 10.1016/j.jinf.2021.03.015. Epub 2021 Mar 22. J Infect. 2021. PMID: 33766553 Free PMC article.
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
Lazarus R, Baos S, Cappel-Porter H, Carson-Stevens A, Clout M, Culliford L, Emmett SR, Garstang J, Gbadamoshi L, Hallis B, Harris RA, Hutton D, Jacobsen N, Joyce K, Kaminski R, Libri V, Middleditch A, McCullagh L, Moran E, Phillipson A, Price E, Ryan J, Thirard R, Todd R, Snape MD, Tucker D, Williams RL, Nguyen-Van-Tam JS, Finn A, Rogers CA; ComfluCOV Trial Group. Lazarus R, et al. Among authors: hallis b. Lancet. 2021 Dec 18;398(10318):2277-2287. doi: 10.1016/S0140-6736(21)02329-1. Epub 2021 Nov 11. Lancet. 2021. PMID: 34774197 Free PMC article. Clinical Trial.
Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5-6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis.
Parry H, Bruton R, Tut G, Ali M, Stephens C, Greenwood D, Faustini S, Hughes S, Huissoon A, Meade R, Brown K, Amirthalingam G, Otter A, Hallis B, Richter A, Zuo J, Moss P. Parry H, et al. Among authors: hallis b. Lancet Healthy Longev. 2021 Sep;2(9):e554-e560. doi: 10.1016/S2666-7568(21)00169-0. Epub 2021 Aug 12. Lancet Healthy Longev. 2021. PMID: 34401865 Free PMC article.
76 results